T
Takeda Pharmaceutical
Tokyo, Japan
Founded 1781 NYSE: TAK
Nanomedicine Drug Delivery Cancer Nanotherapy Lipid Nanoparticles Regenerative Medicine Nanodiagnostics
About
Global pharma with nanomedicine programs
Company Details
- Type
- public
- Employees
- 50000+
- Funding
- Public
Key Products
- Ninlaro
- Entyvio